Related Experiment Video
Updated: Jun 6, 2025

Real-time fMRI Biofeedback Targeting the Orbitofrontal Cortex for Contamination Anxiety
Published on: January 20, 2012
Exploring neurofeedback as a therapeutic intervention for subjective cognitive decline
Véronique Paban1, Lewis Feraud1, Arnaud Weills1
1CNRS-UMR 7077, CRPN, Aix Marseille Univ, Marseille, France.
Neurofeedback (NFB) did not improve cognitive function or EEG signals in aging adults with subjective cognitive decline (SCD). Individualized NFB training showed no significant benefits over standard protocols, indicating NFB may not be an effective early intervention for SCD.
Area of Science:
- Neuroscience
- Cognitive Science
- Biomedical Engineering
Background:
- Subjective cognitive decline (SCD) is a growing concern in aging populations.
- Neurofeedback (NFB) is a brain-computer interface technique explored for neurological and psychological conditions.
- The efficacy of NFB for early intervention in SCD requires further investigation.
Purpose of the Study:
- To evaluate the efficacy of individualized NFB training versus standard NFB protocols for cognitive function in aging adults with SCD.
- To analyze the modulatory effects of NFB on electroencephalographic (EEG) frequencies.
- To investigate personalized NFB approaches tailored to individual EEG profiles.
Main Methods:
- Comparison of individualized NFB training with a standard protocol targeting alpha frequency power.
- Inclusion of a criterion for learning success and a non-learner group.
- Analysis of high-density EEG signals pre- and post-training, alongside questionnaire assessments.
Main Results:
- Individuals with SCD could modulate EEG signal power and duration at various frequencies, not just the target.
- No significant alterations in EEG signal power were observed between pre- and post-NFB training.
- Questionnaire scores showed no significant improvement after NFB training.
Conclusions:
- Individualized NFB training did not demonstrate superior efficacy compared to standard protocols for improving cognitive function in individuals with SCD.
- NFB did not significantly alter EEG signal power in participants with SCD.
- Current NFB protocols may not be effective for addressing subjective cognitive decline in aging populations.
Related Concept Videos
Cognitive Development During Adulthood
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive Therapy
Alzheimer's Disease: Treatment

